Catalysts for Sciegen Pharmaceuticals Inc
49 tracked
Sep 29, 2020
approval
GABAPENTIN — FDA approval
Sciegen Pharmaceuticals Inc
→
Sep 29, 2020
approval
GABAPENTIN — FDA approval
Sciegen Pharmaceuticals Inc
→
Sep 29, 2020
approval
GABAPENTIN — FDA approval
Sciegen Pharmaceuticals Inc
→
Sep 29, 2020
approval
GABAPENTIN — FDA approval
Sciegen Pharmaceuticals Inc
→
Sep 29, 2020
approval
GABAPENTIN — FDA approval
Sciegen Pharmaceuticals Inc
→
Jul 1, 2020
approval
ATORVASTATIN CALCIUM — FDA approval
Sciegen Pharmaceuticals Inc
→
Oct 21, 2019
approval
ATORVASTATIN CALCIUM — FDA approval
Sciegen Pharmaceuticals Inc
→
Oct 21, 2019
approval
ATORVASTATIN CALCIUM — FDA approval
Sciegen Pharmaceuticals Inc
→
Oct 21, 2019
approval
ATORVASTATIN CALCIUM — FDA approval
Sciegen Pharmaceuticals Inc
→
Oct 21, 2019
approval
ATORVASTATIN CALCIUM — FDA approval
Sciegen Pharmaceuticals Inc
→
Oct 21, 2019
approval
ATORVASTATIN CALCIUM — FDA approval
Sciegen Pharmaceuticals Inc
→
Dec 27, 2017
approval
GABAPENTIN — FDA approval
Sciegen Pharmaceuticals Inc
→
Jun 30, 2017
approval
BUPROPION HYDROCHLORIDE — FDA approval
Sciegen Pharmaceuticals Inc
→
Jan 6, 2017
approval
DESOXIMETASONE — FDA approval
Sciegen Pharmaceuticals Inc
→
Aug 17, 2016
approval
BUPROPION HYDROCHLORIDE — FDA approval
Sciegen Pharmaceuticals Inc
→
May 19, 2016
approval
ATORVASTATIN CALCIUM — FDA approval
Sciegen Pharmaceuticals Inc
→
Feb 18, 2016
approval
RELGAABI (GABAPENTIN) — FDA approval
Sciegen Pharmaceuticals Inc
→
Feb 4, 2016
approval
GABAPENTIN — FDA approval
Sciegen Pharmaceuticals Inc
→
Jun 12, 2015
approval
DESOXIMETASONE — FDA approval
Sciegen Pharmaceuticals Inc
→